Iron isomaltoside 1000
- Generic Name
- Iron isomaltoside 1000
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 1370654-58-2
- Unique Ingredient Identifier
- 3M6325NY1R
- Background
Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney Disease, and Anemia, Iron-Deficiency, among others.
- Associated Conditions
- Iron Deficiency (ID), Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
A Rising EU Antitrust Enforcement Tide: 'Exclusionary Disparagement' of Pharma Rivals
The EC fined Teva €462.6 million for abusing its dominant position to delay competition to Copaxone, marking the first time a pharma company was held liable for 'exclusionary disparagement.' This decision highlights the rising tide of antitrust enforcement against disparagement practices in the pharma sector, raising questions about the boundary between legitimate competition and illegal means.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath